IIUM Repository

Computational screening of plant-derived compounds identifies Inophyllum E as a strong inhibitor of pancreatic lipase

Sayyid, Fatima and Ahmad Nadzirin, Izzuddin and Abdul Hamid, Azzmer Azzar and Alias, Norsyuhada (2025) Computational screening of plant-derived compounds identifies Inophyllum E as a strong inhibitor of pancreatic lipase. In: Allied Health Sciences Postgraduate Colloquium 2025| Research Communication and Beyond: Unlocking Postgraduate Potential, 11 - 12 June 2025, Kulliyyah of Allied Health Sciences.

[img]
Preview
PDF - Published Version
Download (648kB) | Preview

Abstract

Introduction: Obesity is a chronic, multifactorial disease that imposes a significant global health burden. Inhibition of pancreatic lipase, a key enzyme in dietary fat absorption, is a validated therapeutic strategy. Orlistat, the only FDA-approved pancreatic lipase inhibitor, is limited by gastrointestinal side effects, prompting the search for safer, plant-derived alternatives. Methods: An in silico high-throughput screening (HTS) approach was used to identify natural phytochemicals with inhibitory potential against human pancreatic lipase (PDB ID: 1LPB). A total of 4,015 phytochemicals were retrieved from the NADI Discovery database, of which 3,578 compounds passed Lipinski’s Rule of Five screening via RDKit. These were docked against pancreatic lipase using AutoDock Vina, with orlistat as the reference inhibitor. Results: The top candidate identified was Inophyllum E, a phytochemical from Calophyllum inophyllum, which demonstrated the highest binding affinity (–12.8 kcal/mol), surpassing orlistat (–6.7 kcal/mol). Molecular docking revealed strong hydrogen bond interactions between Inophyllum E and two catalytic residues, Ser152 and His263, indicating stable binding at the enzyme’s active site. Conclusion: This in silico study identified Inophyllum E as a promising natural inhibitor of pancreatic lipase, showing superior binding affinity and favourable interactions with the enzyme’s catalytic triad compared to orlistat. Further in vitro and in vivo studies are warranted to validate its potential as a lead compound for safer anti-obesity therapeutics.

Item Type: Proceeding Paper (Poster)
Uncontrolled Keywords: Pancreatic lipase inhibitor, Inophyllum E, orlistat, high-throughput screening, molecular docking
Subjects: Q Science > Q Science (General)
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button): Kulliyyah of Allied Health Sciences > Department of Biomedical Science (Effective:1st July 2011)
Depositing User: Norsyuhada Alias
Date Deposited: 21 Oct 2025 17:11
Last Modified: 21 Oct 2025 17:11
URI: http://irep.iium.edu.my/id/eprint/123753

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year